AGENUS INC - 29 Aug 2023 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
10%+ Owner
Signature
/s/ Christine Klaskin, Vice President, Finance
Issuer symbol
INKT
Transactions as of
29 Aug 2023
Net transactions value
+$45,016
Form type
4
Filing time
31 Aug 2023, 18:53:25 UTC
Previous filing
28 Aug 2023
Next filing
06 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INKT Common Stock Purchase $45,016 +29,678 +0.14% $1.52 21,734,887 29 Aug 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Open market purchases reported on this line occurred at a weighted average price of $1.5168 (range of $1.50 to $1.52).
F2 Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.